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Edited by Ivan SadowskiAbstract The eﬀect of Akt on Notch intracellular domain
(NICD)-mediated transcription was investigated. Transfection
experiments revealed that constitutively active Akt down-regu-
lates NICD-dependent transcription. Kinase inactive dominant
negative Akt did not aﬀect NICD transcriptional activity, indi-
cating that Akt kinase activity is responsible for the down-regu-
lation. Studies using histone deacetylase (HDAC) and silencing
mediator of retinoid and thyroid hormone receptor (SMRT)
revealed that modulation of NICD transcriptional activity is
not mediated by an HDAC-dependent mechanism or recruitment
of the co-repressor SMRT. Akt inhibited proper nuclear locali-
zation of NICD, and phosphorylated NICD both in vitro and
caused its hyperphosphorylation in vivo. These results may
suggest possible regulation of NICD transcriptional activity by
Akt-mediated phosphorylation and subsequent inhibition of
proper nuclear localization of NICD.
 2008 Federation of European Biochemical Societies. Pub-
lished by Elsevier B.V. All rights reserved.
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Notch-mediated intracellular signal transduction is an evo-
lutionary conserved pathway, reported to play seminal roles
in cell fate control during embryonic development, cell growth,
diﬀerentiation and apoptosis [1]. Notch is a single transmem-
brane protein containing multiple epidermal growth factor
(EGF)-like repeats in their extracellular domain and cdc10/
ankyrin repeats in their intracellular domain. Upon ligand
binding, proteolytic cleavage of Notch near the transmem-
brane domain occurs, resulting in release of the Notch intracel-
lular domain (NICD) [2,3]. NICD is then translocated to the
nucleus, forming a complex with the transcription factor
CBF1/RBP-Jj, and activates transcription of its target genes
including Hes1 and Hes5 [1,4–6].
CBF1/RBP-Jj functions as a bifunctional transcriptional
regulatory protein with a strong repressive eﬀect in co-transfec-
tion assays using Gal4-CBF1/ RBP-Jj and reporters with Gal4
binding sites, while functioning as a transcriptional activator in
the presence of Notch [7]. Prior to Notch activation, CBF1/Abbreviations: NICD, Notch intracellular domain; dnAkt, dominant
negative Akt; HDAC, histone deacetylase; TSA, trichostatin A;
SMRT, silencing mediator of retinoid and thyroid hormone receptors;
GSK3b, glycogen synthase kinase 3b
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doi:10.1016/j.febslet.2008.04.024RBP-Jj interacts with a co-repressor complex containing
silencing mediator of retinoid and thyroid hormone receptors
(SMRT) and histone deacetylase-1 (HDAC-1) [8]. Upon acti-
vation by Notch, the repressor complex dissociates and NICD
can form a complex with histone acetyltransferase P/CAF,
GCN5, p300 and Mastermind [9–11] to activate downstream
transcription.
Serine threonine kinase Akt/protein kinase B has been re-
ported to play very important roles in cell survival, prolifera-
tion and other physiological functions [12,13] Akt1 was ﬁrst
found as a homolog of the transforming oncogene of the
AKT8 retrovirus [14]. Two additional Akt isoforms have also
been identiﬁed, Akt2 and Akt3 [15,16]. All three Akt family
proteins have a central kinase domain [17] and a pleckstrin
homology domain responsible for lipid–protein and protein–
protein interactions in the amino terminus [18].
Accumulating evidence suggest that Notch signaling inter-
acts with other pathways, such as the mitogen activated pro-
tein kinase (MAPK) [19] and phosphatidylinositol 3-kinase
(PI3K)/Akt pathways [20]. Sade et al. [21] showed that Notch1
associates with tyrosine kinase p56lck and PI3K, and PI3K-
dependent activation of Akt plays a role in regulation of
Notch-mediated anti-apoptotic function. In human T-ALL
cells, pharmacological inhibition of PI3K/Akt causes modula-
tion of Notch1 protein, suggesting an interplay between Notch
and Akt signaling [20]. Very recently, it was reported that
Notch-1 negatively regulates phosphatase and tensin homolog
(PTEN) expression via the downstream Hes1 in leukemic T
cells [22]. The authors also showed that Notch signaling and
the PI3K/Akt pathway synergize in a ﬂy model of Notch-in-
duced tumorigenesis, indicating the evolutionary conserved
interplay between the two signaling pathways. These investiga-
tions prompted us to examine the direct eﬀect of Akt on
Notch-induced signaling. In this report, we used transfection
experiments to examine the eﬀect of constitutive active myri-
stoylated Akt (myr-Akt) co-expression on Notch-dependent
transcription using reporter assays.2. Materials and methods
2.1. Plasmids and vectors
HA-tagged myr-Akt1, a kinase-dead (K179M) dominant negative
Akt1 (dnAkt), myr-Akt2 and myr-Akt3 were described previously
[23,24]. The dnAkt2 (K181A) and dnAkt3 (K177M) mutants were con-
structed using the QuikChange kit according to the manufacturers
instruction (Stratagene). The dnAkt2 mutagenesis primer sequence
was 5 0-CCG CTA CTA CGC CAT GGC GAT CCT GCG AAA
GG-3 0 and the dnAkt3 mutagenesis primer sequence was 5 0-CGA
GAG AAG GCA AGT GGA AAA TAC TAT GCT ATG ATG
ATT CTG AAG-3 0. Flag tagged CBF1 and co-repressor SMRT were
kindly donated from Dr. Walmsley (University of Pennsylvania,blished by Elsevier B.V. All rights reserved.
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Dr. Jongbok Yoon (Yonsei University, Seoul, Korea). The plasmid
pcDNA3-Flag-HDAC1 (H141A) was a gift from Dr. Sung Hee Baek
(Seoul National University, Seoul, Korea). HA-tagged wild type
GSK3b (HA-GSK3b) and kinase-dead dominant negative GSK3b
(HA-dnGSK3b) were gifts from Dr. Jho E.H. (University of Seoul).2.2. Cell culture and transfection
293T cells and Cos7 cells (ATCC) were maintained in Dulbeccos
modiﬁed Eagles medium with 10% fetal bovine serum, 50 U/ml peni-
cillin and 50 lg/ml streptomycin at 37 C under 5% CO2 in a humidi-
ﬁed incubator. The cells were transfected by calcium phosphate in
HEPES buﬀered saline as described [25].
2.3. Reporter assays
293T cells or Cos7 cells (12-well plates) were transfected with 1 lg of
total DNA containing 500 ng of reporter constructs (4 · CSL-Luc;
6 · Notch response elements (6 · NRE-Luc); Hes1-Luc) and analyzed
48 h after transfection. Dual luciferase assays were performed using the
Dual-Luciferase Reporter Assay System (Promega) according to the
manufacturers instruction.
2.4. Western blot and immunoprecipitation
All cells were lysed and processed 48 h post-transfection. Transfec-
ted cells were washed once with phosphate-buﬀered saline (PBS) and
lysed with a lysis buﬀer (20 mM Tris–HCl, pH 7.4, 0.1 mM EDTA,
150 mM NaCl, 1% NP-40, 0.1% Triton X-100, 0.1% SDS, 20 mM
NaF, 1 mM Na3VO4, 1 · protease inhibitor (Roche)). All protein sam-
ples were resolved by 10% SDS–PAGE after boiling 5 min in SDS sam-
ple buﬀer. For Western blot analysis, proteins were transferred onto
nitrocellulose in Tris-glycine-methanol buﬀer and visualized with
appropriate primary antibody followed by HRP-conjugated secondary
antibody and WEST-ZOL plus Western Blot Detection System (iN-
tRON).
For immunoprecipitations (IP), 1 mg of total proteins were incu-
bated overnight in 1 ml of lysis buﬀer with appropriate primary anti-
body at 4 C and then with 30 ll protein A-Sepharose CL-4B
(Amersham) for 2 h. The beads were washed three times with lysis buf-
fer. After complete removal of supernatant, beads were resuspended in
SDS sample buﬀer, boiled 10 min and analyzed by SDS–PAGE and
subsequent Western blots.
The antibodies used are mouse Myc-Tag (9B11) (Cell Signaling),
rabbit HA-probe (Y-11) (Santa Cruz Biotechnology), rabbit b-Tubulin
(H-235) (Santa Cruz Biotechnology), mouse anti-FLAG (Sigma), goat
SMRT (N-20) (Santa Cruz Biotechnology), and rabbit c-Jun (60A8)
(Cell Signaling).
2.5. Immunostaining
Cos7 cells (2105) seeded on glass coverslips in 6-well plates, were
transfected with 4 lg of total DNA and processed for immunostaining
48 h after transfection. Cells were washed with PBS, ﬁxed with 3.8%
paraformaldehyde in PBS for 10 min and permeabilized with 0.05%
Triton X-100 in PBS for 10 min at ambient temperature. The ﬁxed cells
were washed three times with PBS for 5 min each and blocked with 3%
skim milk in PBS for 30 min. Eighty microliters of primary antibody
diluted in 1% skim milk was added per coverslip and incubated for
1 h. Cells were washed 3 times with PBS, incubated with 80 ll of sec-
ondary antibody solution (anti-rabbitt IgG-Oregon Green (Molecular
Probe) or anti-rabbit IgG-Cy3 (Zymed) in 1% skim milk in PBS). Cells
were washed three times for 10 min with PBS, nuclei were stained with
4 0,6-diamidino-2-phenylindole (DAPI) in ﬁrst wash. Coverslips were
mounted on slide glasses and observed by ﬂuorescence microscopy
(Olympus BX50).
2.6. Cell fractionation
Cells seeded at the density of 1106 cells in 100 mm dish were trans-
fected with 6 lg of total DNA. Forty-eight hours post-transfection,
the cells were washed with ice cold PBS, and harvested in cytoplasmic
extraction buﬀer (10 mM HEPES; pH 7.9, 10 mM KCl, 0.1 mM
EDTA, 0.1 mM EGTA, 1 mM DTT, 0.5 mM PMSF) and agitated
for 10 min at 4 C. After addition of NP-40 (ﬁnal 0.5%), the samples
were further agitated for 10 min at 4 C. The samples were then sub-
jected to centrifugation at 13000 rpm in a microcentrifuge (Eppendorf)for 5 min. The supernatant was collected as cytosolic fraction. The nu-
clear pellets were washed two times with cold PBS and resuspended in
a nuclear extraction buﬀer (20 mM HEPES; pH 7.9, 400 mM NaCl,
1 mM EDTA, 1 mM EGTA, 1 mM DTT, 1 mM PMSF). The nuclear
extracts were agitated for 10 min at 4 C and centrifuged at 13000 rpm
at 4 C and the supernatants were collected as nuclear fraction.2.7. Expression and puriﬁcation of the recombinant protein
Mouse Notch1 NICD was excised by EcoRI/BamH1 digestion of
myc-NICD. The insert was then ligated into EcoRI and BamHI predi-
gested the bacterial expression vector pGEX4T-3 (Amersham Pharma-
cia). The recombinant glutathione S-transferase (GST)-NICD fusion
construct was transformed into Escherichia coli BL21. Expression of
GST-NICD fusion protein was induced by the addition 2 mM IPTG
(Amersham Pharmacia). GST-NICD was puriﬁed with glutathione
(GSH)-agarose (Sigma) beads according to the manufacturers instruc-
tion.2.8. Immunocomplex kinase assay
293T cells seeded at the density of 1106 cells in 100 mm dish were
transfected with 10 lg of total DNA, harvested 48 h after transfection.
The 1 mg of whole cell lysates was incubated with HA-antibody and
subsequently treated with protein A-Sepharose CL-4B. The immuno-
complexes were incubated with 1.5 lg of pre-puriﬁed GST-NICD
and in 20 ll kinase reaction buﬀer (20 mM MOPS, 25 mM b-glycerol
phosphate, 5 mM EGTA, 1 mM sodium orthovanadate, 1 mM dithio-
threitol, 112.5 lM ATP, 17 mM magnesium chloride) and 10 lCi [c32-
P]ATP (Amersham) for 10 min at 37 C. The samples containing
32P-labeled proteins were analyzed by SDS–PAGE and subsequent
autoradiography.2.9. In vivo labeling
293T cells seeded at a density of 1106 cells in a 100 mm dish were
transfected with 10 lg of total DNA. Forty-eight hours after transfec-
tion, the medium was changed to phosphate free DMEM supple-
mented with 10% dialyzed FBS and 250 lCi/ml [32P]-orthophosphate
(Amersham). The labeled cells were harvested 12 h after radioiso-
tope-labeling. Myc-tag antibody was added to 1 mg of whole cell ly-
sates and incubated for overnight. Myc-tagged 32P-labeled proteins
were precipitated by adding protein A-Sepharose CL-4B and analyzed
by SDS–PAGE and subsequent autoradiography.3. Results
3.1. Akt down-regulates NICD-dependent transcription
To investigate the eﬀect of Akt on Notch dependent tran-
scription, reporter assays were performed in 293T cells and
Cos7 cells using luciferase reporter constructs. In these stud-
ies, three types of diﬀerent luciferase reporter constructs
including 4 · CSL-Luc with four copies of CSL synthetic
binding sites, 6 · NRE-Luc with six copies of Notch response
elements, and Hes1-Luc containing the promoter region of
Hes-1 were used to investigate the eﬀect of Akt on Notch
dependent transcriptional activity. NICD-dependent tran-
scriptional activity was down-regulated by all Akt isoforms
in both cell lines using all three diﬀerent reporter constructs
(Fig. 1A).
To investigate whether this decrease in NICD-dependent
transcriptional activity was attributable to a reduction in
NICD protein levels by Akt, we performed Western blot anal-
yses in 293T cells and Cos7 cells transfected with myc-NICD
and HA-myr-Akt isoforms (Fig. 1B). We found that protein
levels of myc-NICD did not decrease markedly in cells co-
expressing myr-Akt, suggesting that Notch protein levels can
not account for the eﬀect on NICD dependent transcriptional
activity.
Fig. 1. Myr-Akt isoforms down-regulate NICD-dependent transcription. (A) The cells were transfected with NICD, myr-Akt isoforms, and
luciferase reporter constructs, harvested after 48 h and analyzed by dual luciferase assay (Section 2). (B) The cells were transfected with myc-NICD
and myr-Akt isoforms, harvested after 48 h, then analyzed for myc-tagged NICD levels by Western blot analyses. HA-tagged Akt levels were also
shown by Western blot using HA antibody.
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NICD-dependent transcriptional activity
Since Akt is known to regulate its target proteins by phos-
phorylation, we set out to investigate whether the kinase activ-
ities of Akt isoforms are required for down-regulation of
NICD-dependent transcription. Experiments using kinase-
dead dnAkt isoforms, where lysine residues at the active site
have been replaced with methionine (K179M for Akt1,
K177M for Akt3) or alanine (K181A for Akt2), revealed that
the kinase activity of Akt is indispensable for down-regulation
of NICD-dependent transcription (Fig. 2A). Data in Fig. 2B
conﬁrm again that the inhibitory eﬀect of myr-Akt isoforms
on transcriptional activity of NICD does not result from
Akt-mediated down-regulation of NICD protein levels.
3.3. The regulation of NICD-dependent transcription is not
mediated by an HDAC dependent mechanism or
recruitment of co-repressors
HDACs remove an acetyl group from histones, which pro-
motes the formation of repressive chromatin, to cause inhibi-
tion of gene transcription [8,26,27]. To investigate whether
the Akt-mediated inhibitory eﬀect of Akt on NICD-dependent
transcription is mediated by a mechanism involving HDAC
activity, we treated cells with trichostatin A (TSA) (Calbio-
chem), an HDAC inhibitor, at 5 nM for 24 h after transfection
and performed reporter assays (Fig. 3A). NICD-dependent
transcriptional activity was slightly up-regulated by TSA treat-
ment, however, TSA treatment failed to prevent down-regula-
tion caused by myr-Akt isoforms (Fig. 3A, 5th bar vs. 6th bar;7th bar vs. 8th bar; and 9th bar vs. 10th bar). These results
indicated that regulation of Notch-dependent transcription
by myr-Akt is likely not mediated by an HDAC dependent
mechanism. Experiments using HDAC expression constructs
also conﬁrmed that myr-Akt-mediated repression of NICD
transcriptional activity is independent from HDAC activity
(Fig. 3B). Co-expression of dominant negative HDAC did
not prevent down-regulation of Notch-dependent transcrip-
tional activity by myr-Akt.
CBF1 belongs to a family of CSL proteins with homologs in
Drosophila [Suppressor of Hairless, Su(H)] [28] and in Caeno-
rhabditis elegans (Lag-1) [29]. CBF1 binds to DNA and func-
tions as a transcriptional repressor [7,30]. After binding to
DNA, CBF1 recruits a co-repressor complex that includes
SMRT and HDAC1 [8] to exert its inhibitory eﬀect on tran-
scription. To determine whether NICD-dependent transcrip-
tion is down-regulated by modulating binding of CBF1 and
the co-repressors, co-immunoprecipitation was performed in
293T cells transiently transfected with Flag-CBF1 and SMRT.
Myr-Akt did not increase the association between CBF1 and
SMRT (Fig. 3C), suggesting that recruitment of co-repressor
SMRT is likely not the mechanism responsible for myr-Akt-
mediated down-regulation of NICD-dependent transcription.
3.4. Akt inhibits proper nuclear localization of NICD
In an attempt to ﬁnd the mechanism by which Akt could
down-regulate transcriptional activity of NICD, the eﬀect of
Akt on subcellular distribution of NICD was examined. As
shown in Fig. 4, myr-Akt isoforms eﬀectively inhibited proper
Fig. 2. Kinase activities of Akt isoforms are required for inhibition of NICD transcriptional activity. (A) The cells were transfected with NICD, myr-
Akt/dnAkt isoforms, and luciferase reporter constructs, harvested after 48 h and analyzed by dual luciferase assay. (B) The cells were transfected with
myc-NICD and myr-Akt/dnAkt, harvested after 48 h, then analyzed for myc-tagged NICD levels by Western blots. HA-tagged Akt levels were also
shown by Western blot using HA antibody.
Fig. 3. Inhibition of NICD-dependent transcription by Akt is not mediated by recruitment of co-repressors. (A) 293T cells were transfected with
4 · CSL-Luc, NICD and Akt isoforms for 48 h, treated with 5 nM TSA 24 h post-transfection for an additional 24 h and subjected to dual luciferase
assays. (B) 293T cells were transfected with 4 · CSL-Luc, HDAC1 or HDAC1_H141A, and with various combination of myr-Akt and dnAkt
isoforms as indicated, harvested after 48 h and analyzed by dual luciferase assays. (C) 293T cells were transfected with Flag-CBF1, SMRT, and myr-
Akt1 for 48 h, immunoprecipitated with Flag-tag and subjected to Western blot with SMRT antibody (upper panel), Western blot with SMRT (lower
panel).
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Fig. 4. Active Akt isoforms inhibit proper nuclear localization of NICD. (A) Cos7 cells were transfected with myc-NICD and Akt/dnAkt, harvested
after 48 h, then immunostained using myc and HA antibodies (Section 2). All three Akt isoforms eﬀectively inhibited proper nuclear localization of
NICD. (B) The graph shows the percentage of cells where NICD was localized the in nucleus (N, black bars) or perinuclear cytoplasm (P/N, white
bars). More than 100 myc-positive cells were counted per sample in independent experiments performed triplicate. (C) Cos7 cells were transfected
with myc-NICD and myr-Akt1, harvested after 48 h and fractionated into cytoplasmic (C) and nuclear (N) fraction (Section 2). Each fraction was
subjected to Western blot analyses.
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expression of dnAkt isoforms rescued the mislocalization of
NICD in the perinuclear cytoplasm. The representative immu-
nostaining pictures are shown in Fig. 4A and quantiﬁcation of
the results are indicated in Fig. 4B. In the absence of myr-Akt,
around 90% of exogenous NICD was found in the nucleus.
However, upon co-expression of myr-Akt isoforms, NICD
was shown to be mislocalized to the perinuclear cytoplasm in
more than 60% of myc-positive cells. Interestingly, myr-Akt
isoforms were found to be colocalized with NICD predomi-
nantly in the cytoplasm while dnAkt isoforms were found both
in the nucleus and cytoplasm. Fractionation of cells into cyto-
solic and nuclear fractions essentially produced similar results
(Fig. 4C), indicating that Akt kinase activity may play a major
role for mislocalization of NICD. The results may indicate that
Akt causes down-regulation of NICD transcriptional activity
by interfering with proper nuclear localization of NICD and
blocking the association of NICD with DNA. The experiments
using 293T cells showed identical results (data not shown).
3.5. The regulation of NICD transcriptional activity might be
mediated by phosphorylation of NICD by Akt
Having shown that Akt kinase activity is responsible for
mislocalization of NICD in the perinuclear cytoplasm, weinvestigated whether Akt can directly phosphorylate NICD.
In in vitro kinase assays shown in Fig. 5A, myr-Akt1 eﬀec-
tively phosphorylated GST-NICD in vitro, suggesting that
NICD-dependent transcriptional activity may be regulated
through phosphorylation of NICD by Akt. Glycogen synthase
kinase 3b (GSK3b), which was reported to phosphorylate
NICD in vitro and in vivo [31], could also phosphorylate
NICD. In vivo [32P]-orthophosphate labeling experiments also
indicated that Akt can cause phosphorylation of NICD in
vivo. As quantiﬁed in Fig. 5B (right panel) co-expression of
myr-Akt1 increased 32P-phosphate incorporation into NICD
more than 2-fold, while dnAkt1 did not. These results may
suggest that Akt can modulate the subcellular localization of
NICD and eﬀect transcriptional activity through direct phos-
phorylation.4. Discussion
We have investigated the eﬀect of Akt isoforms on NICD-
dependent transcription. All three myr-Akt isoforms eﬀectively
inhibited NICD-dependent transcriptional activity, but not
dnAkts, indicating that kinase activity of Akt regulates NICD
transcriptional function (Fig. 2). We have also shown that co-
Fig. 5. Akt phosphorylates NICD both in vitro and in vivo. (A). 293T cells were transfected with 10 lg of myr-Akt1 or HA-GSK3b, harvested after
48 h and immunoprecipitated with HA antibody. Immunocomplex kinase assays were performed as described in Section 2. The [32P]-labeled samples
were subjected to SDS–PAGE and subsequent autoradiography. (B) 293T cells were transfected with myc-NICD and Akt1 or pcDNA, labeled with
[32P]-orthophosphate in vivo. The cells were harvested 12 h after radioisotope-labeling. The whole cell lysates were immunoprecipitated using myc
antibody and [32P]-labeled myc-NICD was analyzed by SDS–PAGE and subsequent autoradiography.
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tion of NICD (Fig. 4). Interestingly, dnAkt isoform co-
expressing cells showed moderately increased cytoplasmic
misolocalization as compared to control cells expressing NICD
alone, but the percentage of cells showing cytoplasmic mislo-
calization in dnAkt co-expressing cells is still lower than
myr-Akt co-expressing cells (Fig. 4). This might suggest a ki-
nase activity-independent eﬀect of Akt on NICD transloca-
tion. However, since dnAkt isoform co-expressing cells
showed reporter activities almost comparable to cells express-
ing NICD alone (Fig. 2A), and Akt could phosphorylate
NICD both in vitro and cause hyperphosphorylation in vivo,
we conclude that phosphorylation-dependent cytosolic mislo-
calization of NICD may be the major mechanism by which
Akt causes down-regulation of NICD transcriptional activity.
Indeed, Akt has been shown to modulate subcellular distribu-
tion of cell cycle regulatory proteins like p21 [32] and p27 [24]
and FOXO transcription factors [33,34] by direct phosphoryla-
tion. Nuclear exclusion of FOXO transcription factors by
Akt-mediated phosphorylation was reported to be the major
mechanism by which Akt down-regulates FOXO-dependent
transcription.
Though we showed here that Akt could phosphorylate
NICD (Fig. 5) and the kinase activity of Akt isoforms are re-
quired for down-regulation of NICD transcriptional activity
(Fig. 2), we can not completely rule out the possibility that
Akt-mediated phosphorylation of NICD and Akt-induced
NICD transcriptional repression are not directly coupled.
While preparing this manuscript, Baek et al. [35] reported that
Zinc-induced down-regulation of NICD transcriptional activ-
ity is associated with cytoplasmic retention of NICD via
PI3K-Akt signaling pathway. Their report is in agreement with
our ﬁndings here that Akt activity is responsible for down-reg-
ulation of NICD transcriptional activity by nuclear exclusion
of NICD. It was also demonstrated using fractionated Dro-
sophila embryos and cultured mammalian cells that phosphor-
ylated NICD localized in the nuclear fraction [36,37].
GSK3b acts downstream of Akt, and is negatively regulated
by Akt-mediated phosphorylation [38]. Foltz et al. [31] showedthat GSK3b can phosphorylate NICD and protect NICD
from proteasome-mediated degradation, indicating that
GSK3b could up-regulate NICD transcriptional activity by
controlling NICD protein stability. We also showed that
GSK3b could phosphorylate NICD (Fig. 5A) and inhibition
of GSK3b activity by co-expression of dnGSK3b or inhibition
by LiCl treatment resulted in a moderate decrease of NICD
transcriptional activity (Supplementary Fig. S1). This result
may suggest that the inhibitory eﬀect of Akt on NICD tran-
scriptional activity may in part be mediated by inhibition of
the downstream kinase GSK3b. However, the eﬀect of Akt
on cytoplasmic mislocalization of NICD and subsequent inhi-
bition of transcriptional activity seemed to be directly medi-
ated by Akt, since co-expression of dnGSK3b did not
modulate subcellular distribution of NICD (Supplementary
Fig. S2). We also have shown that treatment with LiCl did
not signiﬁcantly further reduce NICD transcriptional activity
in Akt expressing cells (Fig. S3), indicating that Akt could
eﬀectively inhibit the LiCl-sensitive endogenous GSK3b pool.
Moreover, GSK3b was reported to modulate Notch signaling
by protecting degradation of NICD in proteasomes [31], and
therefore it is not likely that inhibition of NICD transcrip-
tional activity is mediated through GSK3b. However, the eﬀect
of GSK3b on Notch transcriptional activity remains contro-
versial since another other report [39] indicates that GSK3b
can phosphorylate Notch2 and inhibit the transcriptional acti-
vation of Notch target genes.
In summary, we have demonstrated here that myr-Akt iso-
forms cause inhibition of NICD transcriptional activity mainly
by modulation of intracellular distribution, and that phos-
phorylation of NICD by Akt might the main mechanism
responsible for this inhibitory eﬀect.Acknowledgements: This work is supported by a Grant from the Na-
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